Literature DB >> 26728724

Discordant response of CD4(+) T cells to antiretroviral therapy in HIV-infected patients coinfected with hepatitis C virus is accompanied by increased liver damage.

N G Shmagel1,2, K V Shmagel3,4, E V Saidakova1,5, L B Korolevskaya1,5, V A Chereshnev1,6,7.   

Abstract

A study of HIV-infected patients coinfected with hepatitis C virus and receiving antiretroviral therapy (ART) but not treated with interferon was performed. Patients were divided into two groups-with standard and inefficient recovery of CD4(+) T cells. It was found that patients with discordant response of CD4(+) T cells to ART showed heavier destructive processes in the liver than the successfully recovered subjects. They had increased levels of ALT and AST. In these patients, the risk of development of liver cirrhosis is greater.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26728724     DOI: 10.1134/S1607672915060034

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  8 in total

Review 1.  HIV/hepatitis C coinfection natural history and disease progression.

Authors:  Maria D Hernandez; Kenneth E Sherman
Journal:  Curr Opin HIV AIDS       Date:  2011-11       Impact factor: 4.283

2.  Chronic immune activation in the T cell compartment of HCV/HIV-1 co-infected patients.

Authors:  Johan K Sandberg; Karolin Falconer; Veronica D Gonzalez
Journal:  Virulence       Date:  2010 May-Jun       Impact factor: 5.882

3.  Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus.

Authors:  M Puoti; M Bonacini; A Spinetti; V Putzolu; S Govindarajan; S Zaltron; M Favret; F Callea; F Gargiulo; F Donato; G Carosi
Journal:  J Infect Dis       Date:  2000-11-16       Impact factor: 5.226

4.  Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.

Authors:  Ashwin Balagopal; Frances H Philp; Jacquie Astemborski; Timothy M Block; Anand Mehta; Ronald Long; Gregory D Kirk; Shruti H Mehta; Andrea L Cox; David L Thomas; Stuart C Ray
Journal:  Gastroenterology       Date:  2008-03-29       Impact factor: 22.682

Review 5.  HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

Authors:  J T Blackard; K E Sherman
Journal:  J Viral Hepat       Date:  2008-01-17       Impact factor: 3.728

6.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Authors:  Chun-Tao Wai; Joel K Greenson; Robert J Fontana; John D Kalbfleisch; Jorge A Marrero; Hari S Conjeevaram; Anna S-F Lok
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

Review 7.  Molecular mechanisms of liver fibrosis in HIV/HCV coinfection.

Authors:  Claudio M Mastroianni; Miriam Lichtner; Claudia Mascia; Paola Zuccalà; Vincenzo Vullo
Journal:  Int J Mol Sci       Date:  2014-05-26       Impact factor: 5.923

8.  Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection.

Authors:  S K Williams; E Donaldson; T Van der Kleij; L Dixon; M Fisher; J Tibble; Y Gilleece; P Klenerman; A H Banham; M Howard; D P Webster
Journal:  J Viral Hepat       Date:  2013-08-15       Impact factor: 3.728

  8 in total
  1 in total

1.  HCV coinfection of the HIV-infected patients with discordant CD4+ T-cell response to antiretroviral therapy leads to intense systemic inflammation.

Authors:  K V Shmagel; L B Korolevskaya; E V Saidakova; N G Shmagel; V A Chereshnev; L Margolis; D Anthony; M Lederman
Journal:  Dokl Biol Sci       Date:  2018-01-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.